Medicine changes lives.
Research changes the world.
Every day, Mass General Brigham scientists chart new terrain in biomedical research to prevent and treat human disease and advance patient care — locally and across the globe.
Recent News
Benchmarks: Research News and Notes from Mass General Brigham for January 2026
Finding better ways to help patients track their blood pressure, new insights into diabetes, mental health and lots more.
Clinical Trial Provides New Treatments for Patients with HHT, a Rare Genetic Disorder
HHT is a severe disease that often dramatically reduces a person’s quality of life.
Five Things to Know: A Clinical Approach to Street Psychiatry
Street psychiatry is a unique approach to providing unhoused individuals with access to crucial mental health services.
Why Vision Loss Happens—and How Mass General Brigham Scientists Are Fighting Back
Stopping vision loss from retinal disease is one of the biggest challenges in eye health today.
The 2025 Cellie Awards: Marcela’s Favorite Picks
Just for fun, here’s a last list of favorites for 2025, including best book, best movie, best MGB science communicator and more.
Remembering Dr. Joel Habener
Dr. Habener’s groundbreaking studies in the 1970s and 1980s led to the development of GLP-1 medications for diabetes and obesity.
Learning More About How Parents Respond to Digital Alerts of Potential Child Suicide Risk
Researchers found that the alerts mostly led to positive improvements in communication about mental health between parents and children.
An International Research Effort Led by Mass General Brigham is Pioneering Breakthroughs in Rare Blood Cancers
The PETAL consortium is a first-of-its-kind global network of more than 100 investigators and 20 research sites.
Mass General Brigham Research Wrapped for 2025
Looking back at another remarkable year for research at Massachusetts General Hospital, including facts and figures, top stories and more.
The MESH Incubator at Mass General Brigham: Using Technology to Address Challenges in Medical Innovation
The research group has approached the use of artificial intelligence for medical innovation with enthusiasm, while still exercising caution.